FDA Approves Xyosted

10.05.2018

EWING, N.J., Oct. 01, 2018 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ:ATRS) today announced the approval of Xyosted (testosterone enanthate) […]

FDA Approves Vizimpro

09.28.2018

September 27, 2018 – Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Vizimpro […]

FDA Approves Copiktra

09.25.2018

BOSTON–(BUSINESS WIRE)–Sep. 24, 2018– Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve […]

FDA Approves Delstrigo

09.01.2018

KENILWORTH, N.J.–(BUSINESS WIRE) August 30, 2018 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today […]

FDA Approves Jornay PM

08.11.2018

GEORGE TOWN, Cayman Islands–(BUSINESS WIRE)August 09, 2018 –Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”) a wholly owned subsidiary of Highland Therapeutics […]